CHRISTOPHER LYNN: Open Payments
NPI 1922479617 · ROLLING MEADOWS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,307 in 36 payments from 8 companies in 2025. Trend: 2023 $1,118 · 2024 $1,171 · 2025 $1,307
Food & beverage: $1,307
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $516 |
| Teva Pharmaceuticals USA, Inc. | 5 | $212 |
| Otsuka America Pharmaceutical, Inc. | 8 | $187 |
| Alkermes, Inc. | 1 | $110 |
| Vanda Pharmaceuticals Inc. | 3 | $106 |
| Neurocrine BioSciences, Inc. | 3 | $99 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
Products named: VRAYLAR, AUSTEDO XR, REXULTI, LYBALVI, HETLIOZ, INGREZZA, Auvelity, Qelbree.
Industry payments across IL — which companies pay providers there.
